Cargando…
Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications
In recent years, immunotherapy has emerged as a viable and attractive strategy for the treatment of prostate cancer. While there are multiple ways to target the immune system, therapeutic cancer vaccines and immune checkpoint inhibitors have been most successful in late-stage clinical trials. The la...
Autores principales: | Singh, B Harpreet, Gulley, James L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023361/ https://www.ncbi.nlm.nih.gov/pubmed/24435055 http://dx.doi.org/10.4103/1008-682X.122585 |
Ejemplares similares
-
Perspectives on the clinical development of immunotherapy in prostate cancer
por: Cordes, Lisa M, et al.
Publicado: (2018) -
Current Updates on COVID-19 Vaccines and Therapeutics: As of June 2022
por: Lee, Wooseong, et al.
Publicado: (2022) -
Current and emerging trends in prostate cancer immunotherapy
por: Schatz, Adam, et al.
Publicado: (2019) -
Developing immunotherapy strategies in the treatment of prostate cancer
por: Gulley, James L., et al.
Publicado: (2016) -
Update of early phase clinical trials in cancer immunotherapy
por: Lee, Dae Ho
Publicado: (2021)